INVESTMENT

Citi maintains Ascendis Pharma stock at Buy, positive outlook ahead of pivotal trial data

Tomas Kauer - ModeratorTomas Kauer - Moderator
Sep 10, 2024 - 18:00
Citi maintains Ascendis Pharma stock at Buy, positive outlook ahead of pivotal trial data
Read More

Tags:

Previous Article

Rubrik stock shines with raised guidance and strong cloud growth

Next Article

Morgan Stanley raises FCC Co stock outlook, targets 15% upside

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Tomas Kauer - Moderator
Tomas Kauer - Moderator

Related Posts

Algeria declares President Tebboune election winner with 95% of vote

Algeria declares President Tebboune election winner wit...

Tomas Kauer - Mode... Sep 9, 2024

Sunrun CEO Mary Powell sells over $62,000 in company stock

Sunrun CEO Mary Powell sells over $62,000 in company stock

Tomas Kauer - Mode... Sep 11, 2024

3D Systems gains FDA nod for ankle surgery guides

3D Systems gains FDA nod for ankle surgery guides

Tomas Kauer - Mode... Sep 11, 2024